Stock Traders Buy High Volume of Mirion Technologies Call Options (NYSE:MIR)

Mirion Technologies, Inc. (NYSE:MIR) saw some unusual options trading activity on Friday. Investors bought 3,020 call options on the stock. This is an increase of 243% compared to the average volume of 880 call options.

Mirion Technologies Trading Down 1.2 %

Shares of NYSE MIR opened at $15.18 on Friday. Mirion Technologies has a 1-year low of $8.43 and a 1-year high of $15.98. The business has a fifty day moving average price of $12.63 and a 200 day moving average price of $11.29. The stock has a market capitalization of $3.53 billion, a P/E ratio of -44.65 and a beta of 0.73. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.16 and a quick ratio of 1.55.

Mirion Technologies (NYSE:MIR) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.02). The firm had revenue of $206.80 million for the quarter, compared to the consensus estimate of $203.67 million. Mirion Technologies had a positive return on equity of 4.33% and a negative net margin of 7.84%. The company’s revenue was up 8.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.03 EPS. Equities research analysts expect that Mirion Technologies will post 0.36 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently commented on MIR shares. B. Riley began coverage on Mirion Technologies in a report on Thursday, September 26th. They issued a “buy” rating and a $14.00 price objective for the company. Citigroup boosted their price target on Mirion Technologies from $17.00 to $18.00 and gave the company a “buy” rating in a research note on Thursday, October 31st. Finally, The Goldman Sachs Group increased their price objective on shares of Mirion Technologies from $13.00 to $16.00 and gave the stock a “buy” rating in a research note on Thursday, October 31st.

Insider Activity at Mirion Technologies

In related news, CEO Thomas D. Logan sold 7,500 shares of Mirion Technologies stock in a transaction dated Tuesday, September 24th. The stock was sold at an average price of $10.47, for a total value of $78,525.00. Following the completion of the sale, the chief executive officer now directly owns 1,544,017 shares in the company, valued at approximately $16,165,857.99. This trade represents a 0.48 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Emmanuelle Lee sold 3,405 shares of the company’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $14.27, for a total transaction of $48,589.35. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 30,905 shares of company stock valued at $368,439. 2.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Innealta Capital LLC acquired a new stake in Mirion Technologies in the second quarter worth about $39,000. Quest Partners LLC grew its position in Mirion Technologies by 680.5% during the 3rd quarter. Quest Partners LLC now owns 6,728 shares of the company’s stock worth $74,000 after purchasing an additional 5,866 shares during the last quarter. Integrated Advisors Network LLC acquired a new position in Mirion Technologies during the 3rd quarter valued at approximately $120,000. Paloma Partners Management Co acquired a new stake in shares of Mirion Technologies during the third quarter worth $122,000. Finally, Landscape Capital Management L.L.C. purchased a new stake in shares of Mirion Technologies during the third quarter valued at $147,000. 78.51% of the stock is currently owned by hedge funds and other institutional investors.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.